Similar articles

• ESH-ESC guidelines for the management of hypertension.

  Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B. Erdine S, et al. Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3. Herz. 2006. PMID: 16810473
• Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.

  Nielsen FS. Nielsen FS. Dan Med Bull. 2000 Sep;47(4):249-70. Dan Med Bull. 2000. PMID: 11064829 Review. No abstract available.
• [Blood pressure limits for beginning and goal of antihypertensive therapy (3). What is not proven but plausible?].

  Holzgreve H. Holzgreve H. MMW Fortschr Med. 2005 Jul 7;147(27-28):39-40. MMW Fortschr Med. 2005. PMID: 16041940 German. No abstract available.
• [Evaluation of blood pressure control by ambulatory blood pressure monitoring and study of factors associated with poor blood pressure control in 300 treated hypertensive type 2 diabetic patients].

  Ben-Hamouda-Chihaoui M, Kanoun F, Ftouhi B, Lamine-Chtioui F, Kamoun M, Slimane H. Ben-Hamouda-Chihaoui M, et al. Ann Cardiol Angeiol (Paris). 2011 Apr;60(2):71-6. doi: 10.1016/j.ancard.2010.12.004. Epub 2011 Jan 8. Ann Cardiol Angeiol (Paris). 2011. PMID: 21272854 French.
• [Measurement and evaluation of blood pressure].

  Inoue R, Ohkubo T, Kikuya M, Imai Y. Inoue R, et al. Nihon Rinsho. 2006 Aug;64 Suppl 6:494-7. Nihon Rinsho. 2006. PMID: 16981583 Review. Japanese. No abstract available.